1. (2023, December 17). FDA News Release (11 December 2020): FDA Takes Key Action in Fight against COVID-19 by Issuing Emergency Use Authorization for First COVID-19 Vaccine, Available online: https://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19.
2. (2023, December 17). FDA News Release (18 December 2020), FDA Takes Additional Action in Fight Against COVID-19 by Issuing Emergency Use Authorization for Second COVID-19 Vaccine, Available online: https://www.fda.gov/news-events/press-announcements/fda-takes-additional-action-fight-against-covid-19-issuing-emergency-use-authorization-second-covid.
3. Burton, T., and Loftus, P. (Wall Str. J., 2021). J&J Single-Dose COVID-19 Vaccine Gains Backing from FDA Advisory Panel, Wall Str. J.
4. (2023, December 17). AstraZeneca Press Release (30 December 2020). AstraZeneca’s COVID-19 Vaccine Authorised for Emergency Supply in the UK. Available online: https://www.astrazeneca.com/media-centre/press-releases/2020/astrazenecas-covid-19-vaccine-authorised-in-uk.html#.
5. Bates, G., Stake, M., Osinski, K., Ahn, K.-W., Meurer, J.R., and Black, B. The Disappearing COVID-Naïve Population: Evidence from Antibody Seroprevalence in Milwaukee County, Wisconsin (working paper, December 2023).